IGKV1D-22 and neoplasm: S100A8/A9 are overexpressed in the tumor microenvironment (TME) of many solid tumors and are present in tumor cells, infiltrating host cells including leukocytes, and plasma of cancer patients, where their expression level positively correlates with tumor progression and metastasis.